A 4.4-kilobase DNA fragment (T4.4) from a human tumor (comprising part 9, 20, 30, 34) . The viral DNA is integrated in these lesions at a preferential site of the viral DNA, i.e., the El or E2 open reading frame (ORF) region (19, 23) , and in the few cases analyzed, the cervical carcinoma cells contain transcripts from the E6-E7 ORF regions (1, 22, 23) . Even though the role of integration and expression of the HPV DNA sequences in cervical carcinogenesis is far from clear, it is significant that HPV-16 is able to transform NIH 3T3 (32) and C127 mouse cell lines (21), albeit at low efficiency. It can also immortalize human keratinocytes from foreskin (8) and cervix (G. Pecoraro et al., manuscript in preparation). The E6-E7 ORF regions cooperate with the ras gene in the tumorigenic transformation of primary rat fibroblasts (18), whereas the E7 region, when placed under control of an exogenous promoter, can transform immortalized rat cells (13).
A high percentage of human cervical tumors contain human papillomavirus (HPV) DNA sequences, mainly HPV type or HPV-18 (3, 9, 20, 30, 34) . The viral DNA is integrated in these lesions at a preferential site of the viral DNA, i.e., the El or E2 open reading frame (ORF) region (19, 23) , and in the few cases analyzed, the cervical carcinoma cells contain transcripts from the E6-E7 ORF regions (1, 22, 23) . Even though the role of integration and expression of the HPV DNA sequences in cervical carcinogenesis is far from clear, it is significant that HPV-16 is able to transform NIH 3T3 (32) and C127 mouse cell lines (21) , albeit at low efficiency. It can also immortalize human keratinocytes from foreskin (8) and cervix (G. Pecoraro et al., manuscript in preparation). The E6-E7 ORF regions cooperate with the ras gene in the tumorigenic transformation of primary rat fibroblasts (18) , whereas the E7 region, when placed under control of an exogenous promoter, can transform immortalized rat cells (13) .
To determine the biological function of a subset of HPV-16 DNA sequences and to explore the biological significance of integration, we have studied the activity of the DNA isolated from a human lung carcinoma. As reported in the original publication (28) , this anaplastic tumor (WV3262), which contained HPV-16 DNA sequences, could have been either a primary lung carcinoma or a metastasis from a squamous cervical carcinoma which had occurred in the same patient 9 years previously. Several genomic clones containing HPV-16 DNA sequences were isolated from this tumor, among these a clone identified as T4.4, a 4.4-kilobase (kb) EcoRI fragment encompassing and human cellular DNA junction sequences.
As reported in more detail elsewhere (J.-Y. Le et al., manuscript in preparation), the T4. 4 clone contains DNA from nucleotide (nt) 7454 to 1338 (24) , where it joins * Corresponding author. cellular DNA sequences (Fig. 1) ; the viral DNA portion includes part of the upstream regulatory region (URR) and the E6, E7, and parts of the El ORF as determined by mapping analysis. Sequencing of up to 100 base pairs (bp) upstream from nt 1338 did not show any permutation when this sequence was compared with authentic HPV-16 DNA sequences (24) . Partial sequencing of 200 bp downstream from the viral DNA junction revealed a stretch of cellular DNA repetitive sequences with repeat units of about 42 nt; as determined by blot hybridization with human cellular DNA, repetitive sequences continued up to the unique PstI site. The distal portion of the molecule (i.e., the PstI-EcoRI fragment) contained a single copy sequence of 450 bp.
In preliminary experiments, the T4.4 fragment was inserted into pSV2-neo at the EcoRI site and transfected into NIH 3T3 cells by the DNA-calcium phosphate coprecipitation method (31) . After G418 selection, the resistant cells were plated in 0.3% soft-agar plates. Within 2 weeks numerous colonies appeared. The cells derived from one of these colonies inoculated subcutaneously into athymic nude mice produced tumors within 4 weeks.
These results prompted us to determine the role of the viral and cellular DNA sequences in this transformation process. To this end, several subclones and constructs were generated (Fig. 1A) .
The T4. 2763 to 3387), which contains both early and late polyadenylation sites in complementary strands (14) , was joined in both orientations downstream of the early ORFs of pTV1.8 (pTV1.8 PVAE and pTV1.8 PVAL, respectively). Another functional polyadenylation site containing fragments of simian virus 40 (SV40) (nt 3204 to 2533) was cleaved from pSV2-neo (27) and inserted downstream of the early ORFs of pTV1.8 (pTV1.8 SVA) in the sense orientation.
For transfection experiments, all fragments were cleaved from their vectors by EcoRI and BglI digestion. The BamHIlinearized HPV-16 whole genome was also included as a positive control. Transfection was carried out with 1 ,ug of DNA from each fragment together with 0.1 pLg of DNA of intact pSV2-neo and 10 pLg of salmon sperm DNA as carrier. After completion of the G418 selection (2 weeks), the resistant colonies within each group were pooled, expanded, and fed with medium without G418. Cells were harvested 4, 5, and 6 weeks after the transfection and plated in agar. The cells harvested 5 weeks after transfection were also injected subcutaneously into athymic nude mice. Cells transfected with the T4.4 fragment (Ni) were able to form colonies in agar (Table 1) , although with somewhat less efficiency than cells transfected with the whole HPV-16 DNA (N9) (Fig. 2 ). Cells transfected with the viral (N2) or cellular (N3) part alone had a colony-forming efficiency not different from that of the background, and, of the cells transfected with the viral fragment with attached polyadenylation sites (N4, N5, and N6), only the one containing the SV40 polyadenylation sites (N6) had a colony-forming efficiency slightly above back- DNA were coprecipitated with calcium phosphate and added to the medium. On the following day, the precipitate was washed away. and fresh medium was added. Twenty-four hours later, the cells were trypsinized and split 1:10 in Dulbecco modified Eagle medium with 10% fetal calf serum containing 500 ,ug of G418 (GIBCO Laboratories) per ml. The medium was changed every 3 to 4 days. G418 selection was continued for 3 days after complete killing of the cells transfected with salmon sperm DNA alone. At the time after transfection indicated in the table, G418-resistant cells were pooled, and 2.5 x 105 cells per 60-mm petri dish were seeded in 0.33% soft agar. ' Percentage of plated cells forming colonies in agar. Colonies were counted in 20 randomly chosen fields, with four dishes for each group, 4 weeks after being plated.
' Cells from the 5-week pool after G418 selection were inoculated subcutaneously into HSd athymic nude mice (NuBR). Mice were kept under observation for 4 months. (Fig. 3) . As expected (33), the cells transformed by the whole HPV-16 DNA (N9) showed prominent bands of 1.4 and 1.8 kb with a minor band at 4.2 kb, whereas in cells transfected with T4.4 (Ni), there was an intense band at 2.6 kb and a slight signal at 1.7 kb. It is important to note that the same bands were observed when individual probes were used from the viral or the cellular portion of the T4.4 fragment (Fig. 3A and C) . Although all the other cell lines contained the corresponding transfected exogenous DNAs, no transcripts were observed from cellular fragments in N3 or from the viral DNA in N2, N4, N5, and N6, except for two randomly selected agar focusforming lines derived from N6, i.e., N6a and N6b (Fig. 3B) .
Several conclusions can be reached from these experiments: in Ni cells, the 2.6-and 1.7-kb transcripts probably are the extensions of the HPV-16 ORFs into the cell fragment; the cellular fragment per se is not transcriptionally active (Fig. 3C, lane N3) ; and the cellular sequences may act as a cis-acting transcriptional regulator for the upstream viral sequences in a more complex way than by only providing a possible polyadenylation site (see comparisons of the viral transcripts between Ni and N4, N5, and N6 in Fig. 3A) .
In a further attempt to define the role of the cellular sequences, the possibility that this fragment could contain sequences functioning as an enhancer was examined; to this end, Tc2.6 was inserted into pAlO CAT in either orientation at the BamHI and BgIII sites (15) . The constructs were transfected into HeLa and NIH 3T3 cells; no detectable activity of the reporting gene was observed in either cell line (Fig. 4) , thus ruling out the possibility that Tc2.6 functions as a classical enhancer, at least in these two cell lines.
Since the results from the NIH 3T3 transfection experiments strongly suggested a transcription-regulating activity of the cellular flanking sequences and since the previous experiments with the chloramphenicol acetyltransferase (CAT) assay excluded the possibility of Tc2.6 being a transcription enhancer, Tc2.6 was placed in different regions of pSV2 CAT (12) to investigate its role further. In the pSV2 CAT Tc2.6 construct, the SV40 sequences downstream from the CAT gene up to the BamHI site (SV40 nt 2533) of pSV2 CAT were maintained, whereas the EcoRIBamHI fragments (SV40 nt 1782 to 2533) were replaced by Tc2.6 in its original orientation as in T4. 4 (Fig. 1B) . The construct was further modified by the deletion of the SV40 polyadenylation sites contained in the HpaI-BamHI fragment (SV40 nt 2666 to 2533), identified as pSV2 CAT AATc2.6. The results of the CAT assay are shown in Fig. 4 . In both HeLa and NIH 3T3 cells, the plasmid pSV2 CAT Tc2.6 reproducibly had a -2.5-fold-higher activity than the parental pSV2 CAT had. When the sequences containing early SV40 polyadenylation site were deleted, there was no detectable CAT activity (pSV2 CAT AvA). However, replacement of the cellular flanking sequences restored some of the CAT activity (pSV2 CAT AATc2.6). When Tc2.6 was inserted upstream of the SV40 promoter, i.e., pSV2 CAT (U)Tc2.6, CAT activity remained at the same level as that of the parental pSV2 CAT. These results clearly demonstrated (2) in two respects: these authors have demonstrated that the E6-E7 region from HPV-18 with heterologous SV40 polyadenylation sites is sufficient to transform NIH 3T3 and RAT-1 cells when placed under the autologous transcriptional control region and, furthermore, that the E6-E7 fragment is more effective in transformation than the whole HPV-18 DNA. In our case, the HPV-16 E6-E7 region was less effective than the whole HPV-16 DNA (compare Ni with N9) in terms of anchorage-independent growth. The difference may be accounted for by the facts that HPV-18 is more competent per se than HPV-16 in transforming NIH 3T3 cells and that TV1.8, the common viral sequence used here in different recombinant genomes, contains only a portion of the URR of HPV-16, while the complete URR of HPV-18 was employed in the constructs used by Bedell et al. (2) . This latter possibility is more probable, since the same group has identified recently an inducible enhancer in the HPV-18 URR which positively responds to the E6 transacting factor, located approximately 500 bp upstream of the E6 cap site (11). TV1.8 includes only a partial domain of the HPV-16 E6-responsive enhancer (R. Mallon arid. V. Defendi, manuscript in preparation). However, the HPV-16 URR itself, i.e., free from any HPV-16-encoded factor, shows little activity in enhancing CAT gene expression in NIH 3T3 cells (6; our unpublished observation).
The transforming ability of the E6-E7 region coincides with the presence of abundant transcripts. It has been assumed that, in the transcripts from tumor cells such as HeLa, SiHa, and CaSki, the polyadenylation site for integrated HPV-16 or HPV-18 is provided by the contiguous cellular sequences (1, 22) . While this may be the case, we have shown that heterologous polyadenylation sites provided by polyomavirus or SV40 can only marginally raise the transformation activity of E6-E7 constructs in transfected NIH 3T3 cells, and this may occur only with SV40 polyadenylation sequences (N6).
The active transcription of E6-E7 in a few of the individual transformants of N6 in agar, e.g., N6a and N6b, could be due to a transcriptional activation effect of certain cellular sequences near the integration site of TV1.8 SVA. The behavior of N6a and N6b is somehow unexpected. The abundance of the E6-E7 transcripts in these two cell lines is no less than that in Ni (Fig. 3B) . The cells are also anchorage independent; however, neither type grew as tumors in athymic nude mice. There are two ATG sites (nt 84 and 104) in HPV-16 that may be used as an E6 start codon, although the second J. VIROL. NOTES 4425 site seems to be used at least in the majority of transcripts of E6 in cervical carcinoma cells (6, 26) ; in addition, the HPV-16 E6 ORF contains mRNA-splicing donor-acceptor sequences (16, 23) . Therefore, a variant HPV-16 E6 protein with different activities may possibly be produced in response to different gene expression regulations. The tumorigenicity of pooled N6 cells could be due to a few cells from those mixed populations in which TV1.8 SVA was placed under a special regulation that produced transcripts comparable to those from T4.4 (Ni) or from the whole HPV-16 genome (N9). Therefore, different specificities of transcription regulation on these potential transforming genes in HPV-16 or HPV-18 might be a salient feature in the tumorigenicity of these viruses.
It is clear that the T4.4 fragment is consistently competent to express its viral genes and to transform NIH 3T3 cells. Since Tc2.6, the cellular part of T4.4, is transcriptionally silent by itself and fails to induce any detectable transformation traits, it is reasonable to assume that Tc2.6 works in cis to regulate gene expression.
Different interactions between the integrated viral sequences of HPV-16 and HPV-18 DNA and cellular flanking sequences have been postulated as being significant in the biological activity of these viruses. Chromosomal studies have shown that some HPV-18 DNA in HeLa and H4-1 cells is integrated in chromosomal regions near some oncogene such as myc and that the transcription of myc also appears to be activated (7) . There is also evidence that the HPV-18 URR has long-range enhancer activity (29) . However, this has been shown only in HeLa cells, and it is not clear how general the phenomenon of cis activation of cellular oncogenes by integration of HPV DNA may be.
The results of our experiments suggest another possible mechanism; i.e., there are cellular flanking sequences, of which Tc2.6 is an example, that activate in cis HPV DNA regions, which have the capacity of being oncogenic. This appears to be the first evidence that cellular flanking sequences may cis activate the expression of an integrated viral DNA genome. Transcription analysis of HPV-16 and HPV-18 in HeLa (22) and CaSki cell lines and in some cervical tumors (26) has indicated that the viral transcripts combine into cellular sequences. The same process is suggested by transcription analysis in the T4.4-transformed NIH 3T3 cells (Fig. 3) . T4.4 sequences include the normal viral donor sites at nt 800 and 1301 but not the normal acceptor site at nt 3360 (5) . This raises the possibility that the cellular portion of T4.4 contains an important splice acceptor site and a functional polyadenylation site essential to the efficient and stable production of transcripts spanning the HPV-16 E6 and E7 ORF. However, in pSV2 CAT Tc2.6, the placement of Tc2.6 downstream of the polyadenylation site of the CAT transcription unit specifically enhances the expression of the CAT gene, indicating that the putative cis effect of these cellular sequences operates beyond providing the splice process.
Another possible function of Tc2.6 could be to provide sequences for stabilization of mRNA (4) . In eucaryotes, the major known factors contributing to mRNA stabilization are the polyadenylation site and the 5' cap. It would appear that the 5' cap is not involved here, since the viral 5' cap is present in all constructs tested. There are AU-rich sequences in the 3' noncoding region of some genes which have been shown to confer destabilization of mRNA (25) . These sequences should be located upstream of the polyadenylation site. However, the result of the CAT assays in 
